Search Results - "Mehta, Vivek K."

Pancreatic tumors show high levels of hypoxia by Koong, A C, Mehta, V K, Le, Q T, Fisher, G A, Terris, D J, Brown, J M, Bastidas, A J, Vierra, M

“…Because of the dismal outcomes of conventional therapies for pancreatic carcinomas, we postulated that hypoxia may exist within these tumors. Seven sequential…”
Get more information

Phase II trial of preoperative 3D conformal radiotherapy, protracted venous infusion 5-fluorouracil, and weekly CPT-11, followed by surgery for ultrasound-staged T3 rectal cancer by Mehta, Vivek K, Cho, Cheryl, Ford, James M, Jambalos, C, Poen, Joseph, Koong, Albert, Lin, Albert, Bastidas, J Augusto, Young, Harvey, Dunphy, Eamonn P, Fisher, George

“…CPT-11 sensitizes tumor cells to radiation and in combination therapy with 5-fluorouracil (5-FU) results in enhanced cytotoxicity to metastatic colorectal…”
Get more information

Preoperative chemoradiation for marginally resectable adenocarcinoma of the pancreas by Mehta, Vivek K., Fisher, George, Ford, James A., Poen, Joseph C., Vierra, Mark A., Oberhelman, Harry, Niederhuber, John, Augusto Bastidas, J.

“…Only 10% to 20% of patients with pancreatic cancer are considered candidates for curative resection at the time of diagnosis. We postulated that preoperative…”
Get full text

Phase I study of stereotactic radiosurgery in patients with locally advanced pancreatic cancer by Koong, Albert C, Le, Quynh T, Ho, Anthony, Fong, Bryan, Fisher, George, Cho, Cheryl, Ford, Jim, Poen, Joseph, Gibbs, Iris C, Mehta, Vivek K, Kee, Stephen, Trueblood, Ward, Yang, George, Bastidas, J Augusto

“…To determine the feasibility and toxicity of delivering stereotactic radiosurgery to patients with locally advanced pancreatic cancer. Patients with Eastern…”
Get more information

Radiotherapy and erlotinib combined: review of the preclinical and clinical evidence by Mehta, Vivek K

“…Epidermal growth factor receptor (EGFR) is often overexpressed in tumors and has been associated with poor prognosis in some cancer types. The introduction of…”
Get full text

Delivery efficiency of an Elekta linac under gated operation by Cui, Guoqiang, Housley, David J., Chen, Fan, Mehta, Vivek K., Shepard, David M.

“…In this study, we have characterized the efficiency of an Elekta linac in the delivery of gated radiotherapy. We have explored techniques to reduce the beam‐on…”
Get full text

Postmastectomy radiation therapy after TRAM flap breast reconstruction by Mehta, Vivek K, Goffinet, Don

“…Postmastectomy chest wall and nodal radiation therapy decreases local recurrence and improves disease-free and overall survival. Immediate transverse rectus…”
Get more information

Experience with an electronic brachytherapy technique for intracavitary accelerated partial breast irradiation by Mehta, Vivek K, Algan, Ozer, Griem, Katherine L, Dickler, Adam, Haile, Kenneth, Wazer, David E, Stevens, Randy E, Chadha, Manjeet, Kurtzman, Steve, Modin, Sheela D, Dowlatshahi, Kambiz, Elliott, Kelly W, Rusch, Thomas W

“…Phase IV study evaluated the safety and device performance of an electronic brachytherapy system (Axxent Electronic Brachytherapy System) as adjuvant therapy…”
Get full text

Radiotherapy, concomitant protracted-venous-infusion 5-fluorouracil, and surgery for ultrasound-staged T3 or T4 rectal cancer by Mehta, V K, Poen, J, Ford, J, Edelstein, P S, Vierra, M, Bastidas, A J, Young, H, Fisher, G

“…A prospective study was undertaken to evaluate the response and toxicity of neoadjuvant chemoradiotherapy for ultrasound-staged T3 or T4 rectal cancer. Since…”
Get more information

Adjuvant radiotherapy and concomitant 5-fluorouracil by protracted venous infusion for resected pancreatic cancer by Mehta, V K, Fisher, G A, Ford, J M, Oberhelman, H A, Vierra, M A, Bastidas, A J, Poen, J C

“…To assess the toxicity and clinical benefit from adjuvant chemoradiotherapy consisting of protracted venous infusion 5-fluorouracil (5-FU) and concomitant…”
Get more information

Unsuspected abnormalities noted on CT treatment-planning scans obtained for breast and chest wall irradiation by Mehta, V K, Goffinet, D R

“…Three-dimensional treatment planning and CT simulation is widely used for the treatment of a variety of cancers. At the Stanford University Medical Center, a…”
Get more information

Image Guided Stereotactic Radiosurgery for Lesions in Proximity to the Anterior Visual Pathways: A Preliminary Report by Mehta, Vivek K., Le, Quynh-Thu, Chang, Steven D., Chenery, Stafford, Adler, John R.

“…The incidence of optic neuropathy after stereotactic radiosurgery (SRS) is related to the total dose, fraction size, and treatment volume. Theoretically,…”
Get full text

Is Diagnostic Review of Radiotherapy-Planning CT Scans Important in the Conformal Therapy Era? by Smitt, Melanie C, Mehta, Vivek K

“…Detailed CT scans are often acquired during the radiotherapy planning process. This study was performed to determine the incidence of important benign and…”
Get full text

Protracted venous infusion 5-fluorouracil with concomitant radiotherapy compared with bolus 5-fluorouracil for unresectable pancreatic cancer by MEHTA, Vivek K, POEN, Joseph C, FORD, James M, OBERHELMAN, Harry A, VIERRA, Mark A, BASTIDAS, Augusto J, FISHER, George A

“…Radiation therapy (RT) with concurrent 5-fluorouracil (5-FU) administered by protracted venous infusion (PVI) replaced our prior institutional protocol of RT…”
Get full text

Low-dose interleukin 1 and tumor necrosis factor individually stimulate insulin release but in combination cause suppression by Mehta, V K, Hao, W, Brooks-Worrell, B M, Palmer, J P

“…The macrophage-derived cytokines interleukin 1 (IL-1) and tumor necrosis factor (TNF) have direct effects on pancreatic beta cells and have been hypothesized…”
Get more information

Adjuvant chemoradiotherapy for "unfavorable" carcinoma of the ampulla of Vater: preliminary report by Mehta, V K, Fisher, G A, Ford, J M, Poen, J C, Vierra, M A, Oberhelman, H A, Bastidas, A J

“…Adjuvant chemoradiotherapy decreases the risk of local recurrence in patients with adenocarcinoma of the ampulla of Vater and high-risk features. Adjuvant…”
Get more information